These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21699018)
1. Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro. Ge Z; Sanders AJ; Ye L; Wang Y; Jiang WG J Exp Ther Oncol; 2011; 9(2):109-18. PubMed ID: 21699018 [TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH; Chen CL; Li WY; Chen CJ Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191 [TBL] [Abstract][Full Text] [Related]
3. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells. Sung HY; Wu HG; Ahn JH; Park WY Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis. Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949 [TBL] [Abstract][Full Text] [Related]
5. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415 [TBL] [Abstract][Full Text] [Related]
6. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321 [TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development. Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253 [TBL] [Abstract][Full Text] [Related]
8. Functional characterisation of decoy receptor 3 in Crohn's disease. Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087 [TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Lin WW; Hsieh SL Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012 [TBL] [Abstract][Full Text] [Related]
10. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome. Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885 [TBL] [Abstract][Full Text] [Related]
11. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL. Li W; Zhang C; Chen C; Zhuang G Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957 [TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 expression during the menstrual cycle and pregnancy, and regulation by sex steroids in endometrial cells in vitro. Chen HF; Chen JS; Shun CT; Tsai YF; Ho HN Hum Reprod; 2009 Jun; 24(6):1350-8. PubMed ID: 19246462 [TBL] [Abstract][Full Text] [Related]
13. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo. Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297 [TBL] [Abstract][Full Text] [Related]
14. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma. Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206 [TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
16. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030 [TBL] [Abstract][Full Text] [Related]
17. Identification of the functional role of AF1Q in the progression of breast cancer. Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166 [TBL] [Abstract][Full Text] [Related]
18. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof]. Shen HW; Wu YL; Peng SY Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749 [TBL] [Abstract][Full Text] [Related]
19. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells. Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993 [TBL] [Abstract][Full Text] [Related]
20. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells. Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]